Abstract Body

Background

The 2022 multi-country mpox outbreak, driven by MPXV Clade IIb, spread to over 100 countries and highlighted uncertainties around the role of residual smallpox-derived immunity and silent transmission in shaping present-day susceptibility. In West Africa, where historical smallpox vaccination campaigns ended in 1980, large unvaccinated cohorts now coexist with older vaccinated individuals, yet the population-level burden of asymptomatic exposure remains poorly defined.

Methods

We conducted serological and phylogenetic analyses in 176 Nigerian adults: 75 healthcare workers sampled in 2021 and 101 community volunteers sampled in 2023. IgG binding to six MPXV antigens (A29L, A35R, B6R, D6L, H3L, M1R) was measured using a six-plex Luminex assay. Magnitude-breadth scores were calculated to assess immunity, and follow-up samples (median 9 months, n=153) were used to identify ≥2-fold increases in magnitude-breadth scores with boosting against ≥4/6 antigens. Complementary phylogenetic analysis of 105 Nigerian sequenced MPXV genomes was performed to assess transmission dynamics.

Results

At baseline, 24/176 (13.6%) were MPXV-seropositive, predominantly individuals born before 1980, consistent with vaccination-derived immunity. Magnitude-breadth scores were two-fold higher in pre-1980 compared to post-1980 cohorts. Among 153 participants with follow-up samples, 5/153 (3%) demonstrated serological evidence of silent exposure without reported illness (Figure 1); all were seronegative at baseline and mostly male. Antigen-specific boosting was strongest to B6R (11-fold), followed by M1R (6.2-fold) and A35R (5.2-fold), but with marked heterogeneity across individuals. Phylogenetic reconstruction revealed high transmission heterogeneity (k≈0.3), with persistence driven by sporadic superspreading against a background of frequent dead-end infections.

Conclusions

Residual smallpox-derived immunity continues to shape mpox serological profiles in Nigeria, with pre-1980 cohorts showing broader and stronger responses. Evidence of silent exposure in younger, previously seronegative adults highlights under-ascertained transmission. Integrating multi-antigen serology with genomic surveillance may improve detection of covert spread and inform rational, targeted vaccination strategies in African settings.

Table or Figure